Skip to content

Clinical trials

Completed Pulmonary Arterial Hypertension trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Status: Completed Country / region: Mexico Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20061
20071
20083
20092
20101
20111
20121
20132
20172
20192
20213
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion8
United Therapeutics5
Bayer3
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
GB002, Inc.1
Gilead Sciences1
Insmed Incorporated1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension24
Hypertension, Pulmonary7
Hypertension2
Cardiovascular Diseases1
Connective Tissue Diseases1
Eisenmenger Complex1
Familial Primary Pulmonary Hypertension1
Lung Diseases1
Respiratory Tract Diseases1
Vascular Diseases1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.